XML 13 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Public Offering
ATM
Common Stock
Common Stock
Public Offering
Common Stock
ATM
Additional Paid-in Capital
Additional Paid-in Capital
Public Offering
Additional Paid-in Capital
ATM
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Beginning Balance at Dec. 31, 2022 $ 179,631     $ 2     $ 282,566     $ (81) $ (102,856)
Beginning Balance, shares at Dec. 31, 2022       23,713,196              
Exercise of stock options , Shares       68,709              
Stock-based compensation expense 1,348           1,348        
Cumulative translation adjustment arising during the period 53                 53  
Exercise of Stock Options 130           130        
Net loss (16,319)                   (16,319)
Ending Balance at Mar. 31, 2023 164,843     $ 2     284,044     (28) (119,175)
Ending Balance, shares at Mar. 31, 2023       23,781,905              
Beginning Balance at Dec. 31, 2022 179,631     $ 2     282,566     (81) (102,856)
Beginning Balance, shares at Dec. 31, 2022       23,713,196              
Net loss (59,131)                    
Ending Balance at Sep. 30, 2023 125,865     $ 2     287,907     (57) (161,987)
Ending Balance, shares at Sep. 30, 2023       23,813,547              
Beginning Balance at Mar. 31, 2023 164,843     $ 2     284,044     (28) (119,175)
Beginning Balance, shares at Mar. 31, 2023       23,781,905              
Exercise of stock options , Shares       31,642              
Stock-based compensation expense 1,837           1,837        
Cumulative translation adjustment arising during the period 41                 41  
Exercise of Stock Options 85           85        
Net loss (19,522)                   (19,522)
Ending Balance at Jun. 30, 2023 147,284     $ 2     285,966     13 (138,697)
Ending Balance, shares at Jun. 30, 2023       23,813,547              
Stock-based compensation expense 1,941           1,941        
Cumulative translation adjustment arising during the period (70)                 (70)  
Net loss (23,290)                   (23,290)
Ending Balance at Sep. 30, 2023 125,865     $ 2     287,907     (57) (161,987)
Ending Balance, shares at Sep. 30, 2023       23,813,547              
Beginning Balance at Dec. 31, 2023 108,421     $ 2     289,867     34 (181,482)
Beginning Balance, shares at Dec. 31, 2023       23,823,241              
Exercise of stock options , Shares       36,194              
Stock-based compensation expense 2,022           2,022        
Unrealized gain (loss) on marketable securities (20)                 (20)  
Cumulative translation adjustment arising during the period (51)                 (51)  
Exercise of Stock Options 395           395        
Issuance of common stock   $ 76,352 $ 9,900   $ 1     $ 76,351 $ 9,900    
Issuance of common stock, Shares         7,530,000 1,000,000          
Net loss (18,020)                   (18,020)
Ending Balance at Mar. 31, 2024 178,999     $ 3     378,535     (37) (199,502)
Ending Balance, shares at Mar. 31, 2024       32,389,435              
Beginning Balance at Dec. 31, 2023 108,421     $ 2     289,867     34 (181,482)
Beginning Balance, shares at Dec. 31, 2023       23,823,241              
Net loss (67,739)                    
Ending Balance at Sep. 30, 2024 137,455     $ 3     386,582     91 (249,221)
Ending Balance, shares at Sep. 30, 2024       32,589,702              
Beginning Balance at Mar. 31, 2024 178,999     $ 3     378,535     (37) (199,502)
Beginning Balance, shares at Mar. 31, 2024       32,389,435              
Exercise of stock options , Shares       128,354              
Issuance of stock under the employee stock purchase plan (in shares)       32,614              
Stock-based compensation expense 2,862           2,862        
Unrealized gain (loss) on marketable securities (37)                 (37)  
Cumulative translation adjustment arising during the period (1)                 (1)  
Exercise of Stock Options 1,403           1,403        
Issuance of stock under the employee stock purchase plan 149           149        
Net loss (28,335)                   (28,335)
Ending Balance at Jun. 30, 2024 155,040     $ 3     382,949     (75) (227,837)
Ending Balance, shares at Jun. 30, 2024       32,550,403              
Exercise of stock options , Shares       39,299              
Stock-based compensation expense 3,226           3,226        
Unrealized gain (loss) on marketable securities 186                 186  
Cumulative translation adjustment arising during the period (20)                 (20)  
Exercise of Stock Options 407           407        
Net loss (21,384)                   (21,384)
Ending Balance at Sep. 30, 2024 $ 137,455     $ 3     $ 386,582     $ 91 $ (249,221)
Ending Balance, shares at Sep. 30, 2024       32,589,702